Status:
RECRUITING
Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
Lead Sponsor:
University Hospital, Rouen
Conditions:
Thrombotic Thrombocytopenic Purpura (TTP)
Eligibility:
All Genders
18+ years
Brief Summary
The general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymphocytes, in particular follicular helper ...
Detailed Description
Thrombotic thrombocytopenic purpura (TTP) is characterised by profound thrombocytopenia, haemolytic anaemia and organ dysfunction (cardiac, neurological or renal). The current treatment strategy inclu...
Eligibility Criteria
Inclusion
- age over 18
- patients with TTP at any stage of diagnosis (acute phase, lasting remission or not, relapse)
- patients undergoing internal medicine at Rouen University Hospital
- people who have read and understood the information letter
- membership of a social security scheme
Exclusion
- \- a person deprived of liberty by an administrative or judicial decision or a person placed under court protection/guardianship or guardianship
Key Trial Info
Start Date :
May 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 11 2027
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06945861
Start Date
May 11 2023
End Date
May 11 2027
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Rouen Hospital,
Rouen, France, 76031